Clinical Trials Directory

Trials / Unknown

UnknownNCT05973474

The Atherogenic Index of Plasma(AIP) in Patients With Atrial Fibrillation

Prognostic Value of the Atherogenic Index of Plasma(AIP)for Cardiovascular Outcomes in Patients With Atrial Fibrillation

Status
Unknown
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to learn about The Atherogenic Index of Plasma(AIP) in patients with atrial fibrillation(AF). The main questions it aims to answer are: (1)To investigate the correlation between AIP and the occurrence rate of AF. (2) To investigate the correlation between AIP and the occurrence rate of cardiovascular outcome events (MACE events, heart failure, embolism events) in patients with AF. Patients's clinical data including medical history, laboratory tests, and imageological examination will be collected and further analysed.

Detailed description

Baseline demographic data: age, gender, height, weight, systolic blood pressure, diastolic blood pressure, smoking habit, drinking habit, physical activity, fasting blood glucose, medication use (statins, ACEI/ARB, anticoagulant related drugs), basic medical history (hypertension, diabetes mellitus, coronary heart disease).

Conditions

Timeline

Start date
2023-07-30
Primary completion
2024-03-01
Completion
2024-07-01
First posted
2023-08-03
Last updated
2023-08-03

Source: ClinicalTrials.gov record NCT05973474. Inclusion in this directory is not an endorsement.

The Atherogenic Index of Plasma(AIP) in Patients With Atrial Fibrillation (NCT05973474) · Clinical Trials Directory